Saturday, September 6, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Old chemo drug, new pancreatic cancer therapy?

August 26, 2024
in Cancer
Reading Time: 2 mins read
0
PDAC
66
SHARES
597
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

The fight against cancer is an arms race, and one of the most effective weapons in clinicians’ arsenals is immunotherapy. Immune checkpoint therapy has become the standard for treating several types of cancer. However, the Nobel Prize-winning strategy is ineffective for most pancreatic ductal adenocarcinoma (PDAC) patients.

PDAC

Credit: Fearon lab/Cold Spring Harbor Laboratory

The fight against cancer is an arms race, and one of the most effective weapons in clinicians’ arsenals is immunotherapy. Immune checkpoint therapy has become the standard for treating several types of cancer. However, the Nobel Prize-winning strategy is ineffective for most pancreatic ductal adenocarcinoma (PDAC) patients.

“Immune checkpoint therapy is only an option in rare cases of PDAC,” Cold Spring Harbor Laboratory (CSHL) Professor Douglas Fearon says. “It’s only effective for patients with a specific subtype of PDAC—that’s less than 5% of all cases.”

Until recently, it was thought that PDAC didn’t trigger any kind of immune response. In 2023, Fearon and his team confirmed the opposite. Immune cells do go on the attack. But they struggle to infiltrate the deadly tumors, which allows PDAC to avoid destruction. Now, Fearon and former CSHL postdoc Jiayun Li have discovered that a common chemotherapy supplement called folinic acid weakens the cancer’s defenses in mice. They found that folinic acid elevates levels of two anti-cancer immune molecules within PDAC: natural killer T (NKT) cells and type-I interferons. In mice, this leads to a more effective immune response, slower tumor growth, and longer survival.

“We discovered that NKT cells enabled type-I interferon to be produced and, as a consequence, adaptive immune killing and expansion of T cells would occur,” says Fearon. “T cells respond to tumors, but they typically cannot get in there unless type-I interferon is produced. Folinic acid enhances that response.”

PDAC resists immune cells, using a protective shield built from two proteins—CXCR4 and CXCL12. This defensive wall is virtually impenetrable. But when the team treated PDAC tumors with folinic acid, cracks were revealed. The resulting elevated levels of NKT cells and type-I interferons acted like trail markers, highlighting a way past PDAC’s defenses. Cancer-killing immune cells that had been kept outside the wall were able to slip into the tumor and start fighting back.

The Fearon lab now aims to translate its discovery into new therapeutics. They’ve recently partnered with biotech company Autobahn Labs to develop potential drugs targeting CXCR4 and CXCL12. These may one day make immune checkpoint therapy a regular option in the fight against PDAC.

“Translating observations in mice into human therapy has been difficult,” Fearon says. “But if we’re successful, immunotherapy may one day become a viable choice for all patients with PDAC—and every other solid tumor—not just in the rare cases we see today.”



Journal

Proceedings of the National Academy of Sciences

DOI

10.1073/pnas.2403917121

Article Publication Date

8-Jul-2024

Share26Tweet17
Previous Post

Scientific consensus can strengthen pro-climate attitudes in society

Next Post

Unraveling the role of CDCA7 in maintenance of DNA methylation

Related Posts

blank
Cancer

Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients

September 6, 2025
blank
Cancer

Phase II Study Finds Iza-Bren Plus Osimertinib Achieves 100% Response Rate in EGFR-Mutated NSCLC

September 6, 2025
blank
Cancer

COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Enhances Progression-Free Survival in EGFR-Mutated NSCLC

September 6, 2025
blank
Cancer

Study Confirms Accuracy of AI Lung Cancer Risk Model Sybil in Predominantly Black Patients at Urban Safety-Net Hospital

September 6, 2025
blank
Cancer

Microbiome’s Hidden Role in Early Tumor Development

September 6, 2025
blank
Cancer

Natural Medicines Target Tumor Blood Vessels to Halt Cancer Progression

September 5, 2025
Next Post
CDCA7 specifically binds to hemi-methylated DNA in the nucleosome

Unraveling the role of CDCA7 in maintenance of DNA methylation

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27544 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    960 shares
    Share 384 Tweet 240
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    510 shares
    Share 204 Tweet 128
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Exploring Finnish Parents’ Faith After Child Loss
  • Exploring Nurses’ Insights on Employee Assistance Programs
  • Assessing Student Social-Emotional-BEHavioral Risk Factors
  • Reemployment Opportunities for Older Workers in China

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading